Key result
The continued use of inflammable anesthetics adds an estimated $9.4 million to the annual cost of surgical care in the United States, prompting advocacy for their complete ban.
Why the study?
Should inflammable anesthetic agents be banned in the United States due to cost and safety concerns?
Population
Hospitals and surgical care settings in the United States
Comparison
Ban on inflammable/explosive anesthetic agents vs Continued use of inflammable anesthetic agents
Design
Editorial
Authors
Loading...
The authors advocate for a ban on inflammable anesthetics in the US due to lack of pharmacologic advantage, fire risk, and an estimated $9.4 million added to annual surgical costs.
Should inflammable anesthetic agents be banned in the United States due to cost and safety concerns?
The authors advocate for a ban on inflammable anesthetics in the US due to lack of pharmacologic advantage, fire risk, and an estimated $9.4 million added to annual surgical costs.
Fineberg et al. (1980) conducted an editorial in Surgical anesthesia. Inflammable anesthetics vs. Non-inflammable anesthetics was evaluated on Annual cost of surgical care. The continued use of inflammable anesthetics adds an estimated $9.4 million to the annual cost of surgical care in the United States, prompting advocacy for their complete ban.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: